Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Going to hit ¢60 by tomorrow weeee
LRGR is my New 4/20 Med Marjuana Profile on Urgent BOTTOM BOUNCE Alert! ??
TW
The Wolf <thewolf@thewolfofpennystocks.com>
https://www.otcmarkets.com/stock/LRGR/profile...SKULL AND CROSS BONES TOO
Reply|
Today, 6:28 AM
You
Getting too much email from The Wolf <thewolf@thewolfofpennystocks.com>? You can unsubscribe
This message was identified as spam. We'll delete it after 10 days. It's not spam | Show blocked content
COULD LRGR BOUNCE ON 4/20 WITH UP TO
130% IMMEDIATE UPSIDE POTENTIAL?
Dear XYZ and Wolfpack Members,
LRGR (Luminar Media Group, Inc) is my New Alert!
Last Price: .41 | SEC Filings | Latest News
Begin your research at http://www.luminarinc.com
In the spirit of 4/20, Today I bring you a Medical Marjuana play that has been all the rage in the last year and easily one of the most talked about plays in the sector today!
Introducing....LRGR!
LRGR is as pure a BOTTOM BOUNCE play as it gets.
What is a BOTTOM BOUNCE?
A temporary or full recovery/reversal from a prolonged decline or bear market. A bounce could be a small, short-lived recovery in the price of a declining security or signal a full reversal of the price. Frequently, downtrends are interrupted by brief periods of recovery - or small rallies - where prices temporarily rise. This can be a result of traders or investors closing out short positions or buying on the assumption that the security has reached a bottom.
It was only LAST WEEK where LRGR was touching highs of .945! Since then, LRGR's tumble has been fast and furious, finally settling today at the same support levels it has rallied from multiple times in the past.
A return to last weeks highs would yield traders up to 130% GAINS!
Take a look...
LRGR is also no stranger to big rallies in the past.
Look at the year it's had....
So could LRGR be setting up for an EPIC BOUNCE OFF THE BOTTOM?
LRGR - TAKING THE FIGHT TO INSECTS EVERYWHERE!
The Luminar Media Group (LRGR) is essentially a media, marketing and entertainment company now bringing it's expertise to the TherOZap trade name as it develops a global marketing strategy.
LRGR's initial efforts will focus on launching its innovative therapy device - the TherOZap™ - in the United States with additional markets to follow closely.
SO WHAT IS THE THEROZAP?
The patent-pending TherOZap™ is a next generation thermal therapy insect device that reduces the inflammatory response, relieving the symptoms of pain, itch and inflammation associated with bites and stings.
LRGR is working with Jenex as it's marketing partner to manufacture and distribute TherOZap wherever critters and humans live together.
As noted in the company's March Press Release, Jenex received a Class II medical device status from the FDA for its platform technology that is indicated for the relief of the pain, itch, and inflammation from over 20,000 different insect stings and bites, (including bees, wasps, hornets, mosquitoes, black flies and jellyfish). Jenex received approval for the above claims from FDA (United States) in 1997.
LRGR READY TO COMBAT ZIKA & WEST NILE VIRUS WITH THE POWER OF HEMP OIL?
On April 7th, LRGR made headlines with the announcement of the completion of a working prototype TherOZap™ device.
With that, came an agreement has been signed with the University Health Network to test Therozap™ against the Zika and West Nile viruses.
Rob Fia, CEO commented, “We are very excited with the TherOZap™ working prototype. Jenex looks forward to working with UHN to begin the initial testing to determine the effectiveness of the device at inactivating both the Zika and West Nile viruses."
Then, just 2 DAYS AGO, the company announced that they have Initiated tests of a topical cannabidiol (“CBD”) oil from hemp utilizing the TherOZap™ device to determine the effectiveness at inactivating both the Zika and West Nile viruses.
Testing will be coordinated through the Techna Institute at the University Health Network in Toronto, Ontario.
As stated in the press release:
Jenex will work with partners in the medical marjuana industry to create a CBD oil compatible with the TherOZap™ device. Several natural health products in topical formulations with unique delivery systems could be developed.
“We are excited to test our platform technology including our TherOZap™ device with a topical cannabidiol oil. Our platform technology combined with a unique CBD topical delivery system may prove beneficial in potentially combating the increasingly troublesome Zika virus problem now affecting many parts of the world.”
THE BOTTOM LINE
As with all Bottom Bouncers, it is important to stay vigilant. Like many other Pink Sheet stocks, LRGR was recently designated Pink-No Information/Caveat Emptor/delinquent reporting by OTCMarkets.com, so make sure you do your research and DD.
However, with the potential of LRGR's TherOZap device, tremendous History of Rallies from these prices, and a potentially huge Bottom Bounce situation, this may be one 4/20 that you actually never forget!
Make sure you're watching LRGR today for a BOUNCE and Follow on Twitter for Updates + Play-by-Play!
Good Trading,
Richard "The Wolf" Ellis
www.thewolfofpennystocks.com
Home | Trading School | Twitter | Disclaimer | Contact | UNSUBSCRIBE | View in Browser
Please read our Full Disclaimer: http://www.TheWolfofPennyStocks.com/disclaimer
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The paying party may own shares and may liquidate them during the promotional period.
PLEASE NOTE WELL: TheWolfofPennyStocks.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice.
THEWOLFOFPENNYSTOCKS.COM WILL NEVER ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED at THEWOLFOFPENNYSTOCKS.COM &/OR ANY OF OUR SOCIAL NETWORKING AND EMAIL ADVERTISING PLATFORMS.
You are reading this newsletter because you have subscribed via our Opt-In Signup form on our Website. If you have been subscribed by mistake, you may unsubscribe [[manage_your_subscriptions_url]]HERE.
This Newsletter is now owned and operated by Link Media. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Link Media and/or it's subscriber base. Our website and newsletter are for Entertainment purposes only. This newsletter is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. Full disclaimer can be read at http://www.TheWolfofPennyStocks.com/disclaimer
We encourage all to read the SEC INVESTOR ALERT before reading our Newsletter.
Release of Liability: Through use of this email and/or website advertisement viewing or using you agree to hold TheWolfofPennyStocks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. TheWolfofPennyStocks.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by TheWolfofPennyStocks.com or an offer or solicitation to buy or sell any security.
COMPENSATION: TheWolfofPennyStocks.com has been compensated fifty-thousand dollars cash via bank wire by a third party, Ninjanuity LLC for a one day Luminar Media Group, Inc. advertising services contract. TheWolfofPennyStocks.com does not own any shares of LRGR. TheWolfofPennyStocks.com does not investigate the background of any third party. The third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. TheWolfofPennyStocks.com may purchase shares on the open market of any mentioned company following the dissemination of this email. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TheWolfofPennyStocks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and TheWolfofPennyStocks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Further, TheWolfofPennyStocks.com has no advance knowledge of any future events of the profiled companies which includes, but is not limited to, news & press releases, changes in corporate structure, or changes in share structure.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TheWolfofPennyStocks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TheWolfofPennyStocks.com is compliant with the Can Spam Act of 2003. TheWolfofPennyStocks.com does not offer such advice or analysis, and TheWolfofPennyStocks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security's previous day closing price and the high of day price during our promotional coverage.
In preparing this publication, TheWolfofPennyStocks.com has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, TheWolfofPennyStocks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TheWolfofPennyStocks.com is not responsible for any claims made by the companies advertised herein, nor is TheWolfofPennyStocks.com responsible for any other promotional firm, its program or its structure.
Make sure you dump this stock. The wolf got paid to promote it. The SEC is delisting every ticker that does business with this company.
I keep getting emails from insider financial saying this is going to take off. Typical pump and dump
thanks my friend. good luck to you. LRGR$$$$.
who was the alert from
an updated financial and then a positive test result would start this up big time. its the season.
http://www.microcapdaily.com/new-pick-is/ late Monday 17th. Might get it going again. G luck
Penny stock hub sent me a message :
Monday April 17, 2017 New Stock Alert
Luminar Media Group Inc (LRGR)
It’s getting close to mosquito season down south where bug-borne diseases have been working their way across the border. Odds are startlingly high that we’ll be hearing about ZIKA and WEST NILE as health hazards real soon. Luminar Media Group Inc. (LRGR) teamed up with people who may have figured out how to handle those mosquito parasites, for good. So it’s no real surprise the chart has been on a 200% ramp lately, only dipping back to the bottom of the channel last week. That could be our chance to open up this action without burning our fingers:
Expect an early spike in the morning $$$$$$$
Friday sellers on Thursday because of the short week,
loading these cheap ones
$LRGR
This is why I think this will run for another 10 days
Did anyone receive a email alert today on this one? Share if you did and source please. Thx. GL
It's moving up nicely. Almost hit a dollar today.
$LRGR.......
That happens all the time with me...right after I sell. Lol
Just once it would be great if right after you got into a potentially High moving stock the next hour came out with a great earnings report and an hour after that that's some item or drug or Duma hickey is the best thing since sliced bread and that just for fun Gamble multiplies by 100. And at the same time nobody betting against the stock even knows it's there. It's fun to dream
Toronto, Ontario (FSCwire) - Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR) and The Jenex Corporation (Jenex, NEX: JEN.H) report the completion of a working prototype for the patent pending TherOZap™ device. An Agreement has been signed with the University Health Network to test Therozap™ against the Zika and West Nile viruses.
Chris Cook, CEO and Chairman of Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), and global licensee for TherOZap™ outside of Canada comments: “The availability of a working prototype brings us one step closer to releasing this product to market. Expanding the device's effectiveness to the Zika and West Nile virus will provide tremendous benefit for many regions of the world.” Images of the Therozap™ prototype can be viewed at www.therozap.com .
Jenex has optimized the features on the TherO Zap ™ working prototype device as protection against both the Zika virus and West Nile virus and potentially other mosquito borne diseases. Jenex has signed an agreement with University Health Network (“UHN”) to initiate testing of the TherO Zap ™ device against these viruses. Over the next several weeks Jenex will be coordinating with the Techna Institute at UHN to devise the protocols for the initial tests. It is anticipated that once all testing is complete, Jenex will commercialize TherOZap™, pending regulatory approval where required.
Rob Fia, CEO commented, “We are very excited with the TherO Zap ™ working prototype. Jenex looks forward to working with UHN to begin the initial testing to determine the effectiveness of the device at inactivating both the Zika and West Nile viruses."
About Jenex
Jenex is a progressive medical device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at the core of Jenex’s philosophy as is the belief that such outcomes should not be a privilege for only those who can afford costly procedures and treatments. The Company's breakthrough proprietary thermal therapy technology uses heat and light energy to deliver effective, non-invasive and pain free skin care. Jenex received a Class II medical device status from the FDA for its platform technology that is indicated for the relief of the pain, itch, and inflammation from over 20,000 different insect stings and bites, (including bees, wasps, hornets, mosquitoes, black flies and jellyfish). Jenex received approval for the above claims from FDA (United States) in 1997.The Jenex Corporation trades on the NEX (NEX:JEN.H). For more information visit: www.thejenexcorporation.com or www.interceptcs.com
About Techna Institute:
Techna is an institute of the University Health Network, in collaboration with the University of Toronto, focused on the accelerated development and exploitation of technology for improved health. Techna is designed to shorten the time interval from technology discovery and development to application for the benefit of patients and the health care system. It also stimulates and facilitates the innovation cycle through a continuum of clinically driven innovation, technology & process development, and translational research. For more information visit: technainstitute.com
About University Health Network:
University Health Network (UHN) is a major landmark in Canada’s healthcare system and a teaching partner of the University of Toronto. UHN consists of Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener Institute for Education at UHN. The scope of research and complexity of cases at University Health Network has made it a national and international source for discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. For more information visit: www.uhn.ca
About Luminar:
The Luminar Media Group has extensive knowledge and experience in the media, marketing and entertainment industries. Luminar will bring this expertise to the TherOZap trade name and is developing a global marketing strategy. Initial efforts will focus on launching its innovative therapy device in the United States with additional markets to follow closely. The company was started by entrepreneurs who can identify new tools to communicate with a target audience. At Luminar, we embrace the challenge of the constantly evolving business landscape and our determined culture will develop solutions that evolve with the changing business paradigm.
Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), reports that the development of the working prototype for the patent pending TherOZap(TM) is scheduled for completion prior to the end of March 2017. A selection of features and optimal components have been finalized for the working prototype. As previously reported Jenex expects to test the working prototype to determine its effectiveness at inactivating both the Zika and West Nile virus and potentially other mosquito borne diseases. Testing will be initiated by a world renowned scientific research lab upon completion of the working prototype.
Luminar CEO, Chris Cook commented;
"As we approach the home stretch of product development, Luminar is looking forward to the next stage of the product development where we can focus on sales and marketing strategies."
Rob Fia, Jenex CEO commented:
"We are pleased to have advanced the design process further with our TherOZap(TM) device and excited to finalize the working prototype."
Jenex received a Class II medical device status from the FDA for its platform technology that is indicated for the relief of the pain, itch, and inflammation from over 20,000 different insect stings and bites, (including bees, wasps, hornets, mosquitoes, black flies and jellyfish). Jenex received approval for the above claims from FDA (United States) in 1997.
About Jenex
Jenex is a progressive medical device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at the core of Jenex's philosophy as is the belief that such outcomes should not be a privilege for only those who can afford costly procedures and treatments. The Company's breakthrough proprietary technology delivers effective, non-invasive and pain free skin care. The Jenex Corporation trades on the NEX (NEX:JEN.H). For more information visit: www.thejenexcorporation.com or www.therozap.com
You think it will hit $2's like the last 2yrs?
10k should be due soon.
This gal ran up in the $2's back in 15 and 16. Similar time frames too. Looks like .80 is resistance and there is nothing in the way after that. It's all a bit strange. Could it run up in the $2's again. Why? GL
Hmm, do we hit a dollar tomorrow??
But pay dividends if your in the right one
How much $ did they spend?
Bought 20k shares last week looking for 1.00 + on this !!!
:))) Lets see :)
Shhhhhhh
PRO TRADER wrote that BARCHART has an 80% overall BUY recommendation !!!
P & D for Monday
Lots of pumpers.
LRGR stock alert for Friday March 31 by FORTUNE STOCK ALERTS / OTC ROCKSTAR / PENNY STOCK TITANS / PENNY PICK ALERTS !!!
Followers
|
19
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
628
|
Created
|
04/29/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |